9/18/2025

HOLX's global push shows strength, with surgical growth and rising diagnostics use offsetting near-term challenges.

Source: Yahoo

9/18/2025

The United States Next Generation Sequencing (NGS) Market is projected to surge to USD 16.57 billion by 2033, up from USD 3.88 billion in 2024, achieving a CAGR of 17.5% between 2025 and 2033. Key drivers include rising demand for personalized medicine, agricultural advancements, and innovations in data analysis and automation. This market growth is bolstered by significant government funding and increasing NGS adoption in clinical diagnostics. Leading companies such as Illumina and Thermo Fishe

Source: Yahoo

9/17/2025

Shuimu BioSciences, a Chinese start-up specialising in advanced imaging devices for viruses and smaller biomolecules, is aiming for an initial public offering in 2027 after selling its first self-developed product this year, according to CEO Allen Guo Chunlong. The company focuses on cryo-electron microscopy (Cryo-EM), a technique that involves firing beams of electrons at flash-frozen specimens to capture thousands of images. The images are then used to reconstruct precise three-dimensional str

Source: Yahoo

9/16/2025

Thermo Fisher unveils the Olink Target 48 Neurodegeneration panel to accelerate biomarker research in neurodegenerative diseases.

Source: Yahoo

9/16/2025

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.2% and the actively trad

Source: Yahoo

9/16/2025

- Strategic expansion with trusted partner enhances customer reachHOLLISTON, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), a leading provider of innovative laboratory equipment, is pleased to announce the expansion of its distribution agreement with Fisher Scientific, a part of Thermo Fisher Scientific, one of the world’s largest and most trusted scientific suppliers. Under this new agreement, Fisher Scientific will now

Source: Yahoo

9/15/2025

WALTHAM, Mass., September 15, 2025--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the Olink® Target 48 Neurodegeneration panel, a high-performance, targeted proteomics immunoassay panel developed to accelerate discoveries in neurodegenerative disease research. With diseases such as Alzheimer’s, multiple sclerosis and Parkinson’s on the rise and clinical pipelines eager for translational biomarkers, researchers face a pressing need for scalable,

Source: Yahoo

9/15/2025

Thermo Fisher Scientific is a high-quality, defensive investment with a strong moat but faces revenue growth headwinds and limited upside. Learn more about TMO stock here.

Source: SeekingAlpha

9/15/2025

Zacks' strategies continue to outpace the market in 2025, with standout gains from CommScope, Micron, Oracle, and others across multiple model portfolios.

Source: Yahoo

9/15/2025

WALTHAM, Mass., September 15, 2025--Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ Efficient-Pro™ Medium (+) Insulin, a next-generation medium designed to increase titers to maximize productivity and elevate the performance of insulin-dependent CHO cell lines. Efficient-Pro Medium (+) Insulin is the latest addition to Thermo Fisher’s existing Efficient-Pro medium and feed system, designed to provide optimized growth and productivity for insulin-depe

Source: Yahoo

9/13/2025

Thermo Fisher Scientific recently presented at the Morgan Stanley Global Healthcare Conference and announced that CFO Stephen Williamson will retire in March 2026, with James R. Meyer named as his successor, while the CEO sold US$200,000 in shares under a pre-arranged plan. These leadership changes and executive share sales come amid shifting analyst sentiment and highlight the importance of management continuity during a period of industry transformation and investor attention to succession...

Source: Yahoo

9/12/2025

Thermo Fisher Scientific Inc. stock falls Friday, underperforms market

Source: MarketWatch

9/11/2025

Shares of life sciences company Thermo Fisher (NYSE:TMO) jumped 2.7% in the afternoon session after Barclays upgraded the stock to Overweight from Equalweight and boosted its price target, citing a more attractive valuation and clearer growth outlook.

Source: Yahoo

9/11/2025

Some of the stories Wall Street is watching on Thursday, Sept, 11 include Citi raising its price target on shares of Micron Technology (MU), Bank of America downgrading FedEx (FDX), and Barclays upgrading shares of Thermo Fisher Scientific (TMO). Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Source: Yahoo

9/11/2025

Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market

Source: MarketWatch

9/11/2025

Apple downgraded, Nvidia upgraded: Wall Street's top analyst calls

Source: Yahoo

9/11/2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This has capped the upside for healthcare stocks lately as the industry’s flat return over the past six months has trailed the S&P 500’s 17.4% gain.

Source: Yahoo

9/10/2025

Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market

Source: MarketWatch

9/10/2025

Renaissance Investment Management, an investment management company, released its Q2 2025 “Large Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. The stock market experienced significant volatility in the second quarter, and yet, the S&P 500 posted an all-time high by the end of June. The liberation day tariff announcement […]

Source: Yahoo

9/10/2025

Thermo Fisher Scientific Inc. (NYSE:TMO) is among the undervalued wide moat stocks to buy now. On Tuesday, Thermo Fisher Scientific Inc. (NYSE:TMO) announced the completion of its acquisition of Solventum Corporation’s purification and filtration business. This $4.0 billion transaction is aimed at expanding the company’s bioprocessing and adjacent market offerings. While providing growth and synergy […]

Source: Yahoo